- Advertisement -
- Advertisement -
- Advertisement -

Find a job

Subscribe for free

All things Pharma


European Medicines Group elects new chair

The European Medicines Group (EMG) has elected UCB Pharma’s Managing Director Matthew Speers as its new chair.

Speers takes over from Nigel Brooksby (sanofi-aventis) and will be supported by the new vice-chair, Lundbeck Managing Director Steve Turley.

Formed in 2001 by 16 research-driven pharmaceutical companies who develop and supply prescription medicines to the NHS, the EMG focuses on access to medicines.

On his appointment, Matthew Spears said: “Despite the tremendous advances in research and development we continue to face considerable market access challenges in the UK with uptake of innovative medicines still lagging significantly behind Europe.

“I am delighted to have been elected to lead the EMG and to continue the work we have undertaken to ensure that all UK citizens have timely access to appropriate, innovative medicines taking other countries in Europe as our benchmark.”

Working alongside the government, the NHS and ABPI, EMG aims to increase the awareness of patients, carers and policy-makers of the European pharma industry’s contribution to the health and wealth of the UK.

“The European perspective is an important one, as European healthcare systems tend to be founded on social values that are closely aligned with those of the NHS,” added Steve Turley.

“We will continue to hold the mirror up to Europe and work together with government, clinicians and patients to improve the health and quality of life of people in the UK.”


Matthew Speers and Steve Turley

- Advertisement -


- Advertisement -



Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription